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Background: The human leukocyte antigen (HLA)-B27 gene is considered to be a major gene associated with
predisposition to ankylosing spondylitis (AS); however, studies have demonstrated that non-HLA-B27 genes also
contribute substantially to the susceptibility to AS. Two single nucleotide polymorphisms (SNPs), rs1004819 and
rs10889677, of the interleukin-23 receptor (IL-23R) gene have been shown to be associated with AS susceptibility in
European populations. However, ethnicity factors contribute to population splitting and genetic variation, and
ethnic-specific genetic association studies are needed to validate these associations in patients from different ethnic
backgrounds. This study therefore aimed to replicate the associations between these two SNPs and AS
susceptibility in a Chinese Han population.
Methods: A total of 195 AS patients and 203 normal controls were recruited in this study. Two IL-23R gene SNPs,
rs1004819 and rs10889677 were selected. Genotyping was performed in all subjects using the TaqMan probe
method. Genotype and allele frequencies were compared between AS patients and normal controls by χ2 tests.
Results: There were no significant differences in either the genotype frequencies (TT 36.4%, TC 48.7% and CC 14.9%
in AS patients; TT 35.0%, TC 50.0% and CC 15.0% in normal controls) or allele frequencies (T 60.8% and C 39.2% in
AS patients; T 60.0% and C 40.0% in normal controls) of rs1004819 between AS patients and normal controls
(P > 0.05). In addition, both the genotype frequencies (AA 51.3%, AC 43.1% and CC 5.6% in AS patients; AA 57.6%, AC
35.5% and CC 6.9% in normal controls) and allele frequencies (A 72.8% and C 27.2% in AS patients; A 75.4% and C
24.6% in normal controls) of rs10889677 were also comparable between AS patients and normal controls (P > 0.05).
Conclusions: This study found no evidence for an association between either of the two previously identified
AS-susceptibility IL-23R SNPs (rs1004819 and rs10889677) and onset of AS, indicating a possible difference in
pathogenesis of AS between Chinese and European patients.
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Table 1 Sequences of primers and probes for SNP
rs1004819 and rs10889677
SNP Products Sequence
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Ankylosing spondylitis (AS) is an autoimmune-related
disease characterized by chronic inflammations and gra-
dual ossifications of the spine and sacroiliac joints [1].
Substantial evidence suggests that genetic predisposition
has a significant impact on individual susceptibility to
AS [2]. Although the human leukocyte antigen (HLA)-
B27 gene is considered to be a primary gene associated
with predisposition to AS and confers disease suscepti-
bility, it is unable to explain all cases of AS and its con-
tribution to the overall genetic predisposition is only
20–30% [3]. Increasing evidence suggests that other,
non-HLA-B27 genes also play crucial roles in AS sus-
ceptibility [4-6].
The etiology of AS is characterized by aberrant regula-
tions of both the adaptive and innate immune responses
[7], suggesting that inflammatory mediators involved in
the regulations of immunological reactions could be
potential candidate genes. The interleukin-23 receptor
(IL-23R) is a member of the hematopoietin receptor
superfamily, and constitutes a specific component of the
heterodimeric receptor for the cytokine IL-23 [8]. IL-
23R plays a key role in the differentiation of CD4 T-cell
into TH17 lymphocytes, which mediate inflammations
in several animal models of autoimmunity [9,10]. IL-23R
gene polymorphisms may thus be implicated in suscepti-
bility to human autoimmune diseases, such as AS [11].
A recent genome-wide association study reported that
the IL-23R gene conferred susceptibility to AS [12], while
IL-23R gene variation was responsible for 9% of the
population-attributable risks of AS [12]. The associations
between IL-23R gene polymorphisms and AS susceptibil-
ity have been confirmed in European populations by
genetic association studies [13-15], though the genotype
distributions may differ among patients with different eth-
nic backgrounds [16]. Ethnic-specific genetic association
studies are therefore needed to validate the associations
between IL-23R gene polymorphisms and AS susceptibil-
ity. The aim of this study was to reevaluate the identified
associations between two IL-23R gene single nucleotide
polymorphisms (SNPs), rs1004819 and rs10889677, and
AS susceptibility in a Chinese Han population.
Methods
Subjects
The study population consisted of 195 sequential unre-
lated AS patients (183 men and 12 women) and 203
age- and gender-matched normal controls (178 men
and 25 women) recruited from January 2008 to January
2012. All the subjects investigated were of Chinese Han
ethnicity. All the AS patients were recruited from the
outpatient clinic of the affiliated Drum Tower Hospital
of Nanjing University Medical School, while the normal
controls were recruited from the medical control centerfor the healthy population at the hospital. The average age
of the AS patients was 32 years (range, 21–53 years), and
all patients satisfied the modified 1984 New York criteria
[17]. The normal controls were healthy subjects with no
autoimmune or musculoskeletal disease, with an average
age of 37 years (range, 26–57 years). One hundred and
ninety-two AS patients (98.5%) were HLA-B27-positive
and all the normal controls were HLA-B27-negative.
Ethical approval was obtained from the research ethics
committee of the medical school of Nanjing University
and informed consent for DNA analysis was obtained
from all subjects.Genotyping
Genomic DNA was extracted from peripheral blood leu-
kocytes using genomic DNA isolation kits (Promega,
Madison, WI, USA) according to the manufacturer’s
instructions. Two IL-23R SNPs (rs1004819 and rs10889
677) were selected for analysis. Genotyping was perfor-
med using the TaqMan Probe method with an ABI 7500
Real-time PCR system (Applied Biosystems, Foster City,
CA, USA). The primers were designed by Primer Prem-
ier 5.0 and are listed in Table 1. The polymerase chain
reaction system consisted of 5 μl 2 × TaqMan Master
Mix, 0.5 μl of each primer (10 nmol/l), 0.25 μl of each
probe (10 nmol/l), 2 μl DNA sample and 1.5 μl of sterile
deionized water. The mixture was incubated for 5 min
at 94°C, followed by 35 cycles of 94°C for 30 s, 58°C
(for rs1004819) or 60°C (for rs10889677) for 30 s, 72°C
for 1 min, and a final extension at 72°C for 7 min. Of
these samples, 10% were tested twice to validate the
genotyping results, with 100% reproducibility.Statistical analysis
Statistical analysis was performed using SPSS software
(version 16.0, SAS, Inc, Chicago, IL, USA). The genotype
and allelic frequencies in AS patients and normal con-
trols were compared using χ2 tests. P < 0.05 was consid-
ered to be statistically significant.
Table 2 Allele and genotype frequencies of SNP
rs1004819 and rs10889677 in ankylosing spondylitis








rs1004819 TT 71 (36.4%) 71 (35.0%) 0.09 0.96
TC 95 (48.7%) 101 (50.0%)
CC 29 (14.9%) 31 (15.0%)
T 237 (60.8%) 243 (60.0%) 0.07 0.79
C 153 (39.2%) 163 (40.0%)
rs10889677 AA 100 (51.3%) 117 (57.6%) 2.46 0.29
AC 84 (43.1%) 72 (35.5%)
CC 11 (5.6%) 14 (6.9%)
A 284 (72.8%) 306 (75.4%) 0.67 0.41
C 106 (27.2%) 100 (24.6%)
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The genotype frequencies of these two SNPs did not de-
viate significantly from the Hardy-Weinberg equilibrium
in either the AS patients or controls.
The genotype frequencies for rs1004819 were TT
36.4%, TC 48.7% and CC 14.9% in AS patients, and TT
35.0%, TC 50.0% and CC 15.0% in normal controls. The
allele frequencies were T 60.8% and C 39.2% in AS pa-
tients, and T 60.0% and C 40.0% in normal controls
(Table 2). Neither the genotype nor the allele frequencies
of rs1004819 differed significantly between AS patients
and controls (P > 0.05). The genotype frequencies for
rs10889677 were AA 51.3%, AC 43.1% and CC 5.6% in
AS patients, and AA 57.6%, AC 35.5% and CC 6.9% in
normal controls. The allele frequencies were A 72.8%
and C 27.2% in AS patients, and A 75.4% and C 24.6%
in normal controls (Table 2). The genotype and allele
frequencies of rs10889677 were also comparable be-
tween AS patients and normal controls (P > 0.05).
Discussion
A substantial proportion of AS genetic susceptibility is
known to be encoded by non-HLA genes [5], among
which the IL-23R gene has been reportedly associated
with the onset of AS in European populations in previ-
ous genetic association studies [13-15]. The IL-23RTable 3 Allele frequencies of SNP rs10889677 in European an
Ankylosing spondylitis patients (%)
Allele A C Number
British [12] 36% 64% 1818
Hungarian [13] 34.5% 65.5% 206
Portuguese [14] 28% 72% 358
Chinese Han 72.8% 27.2% 195
*compared with Chinese Han population.SNPs rs1004819 and rs10889677 have both been found
to confer risks of AS susceptibility in British [13],
Hungarian [14] and Portuguese populations [15]; how-
ever, ethnic factors contribute greatly to population split-
ting and genetic variation and genotype distributions
may differ significantly among different ethnic groups
[16]. The SNP rs1004819 is an A/G variation in these
European populations, but a C/T variation in the Chinese
Han population. Additionally, although rs10889677 is an
A/C variation in both European and Chinese Han popula-
tions, the allele frequency distribution of this SNP differs
significantly between these populations, according to the
results of previous European studies (Table 3). Data
obtained from the International Hapmap Project (http://
hapmap.ncbi.nlm.nih.gov/) also demonstrated wide varia-
tions in allele frequencies for these two SNPs between dif-
ferent races. The associations between these two SNPs and
AS susceptibility demonstrated in European populations
thus need to be confirmed in the Chinese Han population.
The IL-23R gene encodes an important cytokine re-
ceptor in the Th17 subset of T lymphocytes [18,19], and
IL-23R, together with IL-12Rβ1, comprises the IL-23 re-
ceptor complex in IL-23-responsive cells [20]. IL-23 is
one of the major regulators of innate and adaptive im-
munities [8]. It stimulates a unique CD4+ inflammatory
T-cell characterized by secretion of IL-17, tumor necro-
sis factor and IL-6, which are strongly associated with
proinflammatory responses and severe autoimmunity
[8]. These conclusions suggest a possible involvement of
the IL-23/IL-23R pathway in the etiology of AS. SNP
rs1004819 and SNP rs10889677 are located in the in-
tronic region and 3’-untranslated (3’-UTR) region of the
IL-23R gene, respectively [7]. rs1004819 may exert its in-
fluence by regulating differential splicing of IL-23R
mRNA, while rs10889677 may lead to variation in the
3’-UTR region, which could be associated with reduced
binding of IL-23R mRNA [14]. Both these variations
may have functional consequences for the IL-23R path-
way and could provide a possible explanation for the
associations between these two variants and AS suscepti-
bility in European populations.
Despite the positive associations between these two
SNPs and AS in European populations, neither rs100
4819 nor rs10889677 was found to be related to ASd Chinese Han populations
Normal controls (%)
P* A C Number P*
0.000 28.5% 71.5% 1331 0.000
0.000 31% 69% 235 0.000
0.000 36% 64% 285 0.000
75.4% 24.6% 203
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allele frequencies of both SNPs were similar in AS patients
and controls, indicating that neither variation in the IL-
23R gene was relevant to the etiology of AS. These results
suggest that the mechanism responsible for AS may differ
between Chinese and European patients, and that AS in
Chinese patients may develop through a mechanism inde-
pendent of these two IL-23R gene variants. Our results
support the idea that different disease mechanisms exist in
different ethnic populations [16], and a different predis-
position gene may be involved in the IL-23/IL-23R signal-
ing pathway in Chinese AS patients. However, we only
investigated two SNPs in our study, and therefore cannot
completely exclude a role for IL-23R gene in the develop-
ment of AS in Chinese populations. Further studies
including other SNPs that cover the IL-23R gene are ne-
cessary to clarify its true role in AS susceptibility.Conclusions
In conclusion, the results of this study differed substantially
from those of previous European studies. We suggest that
this discrepancy can be attributed to racial differences, in-
dicating the need to perform genetic association studies in
different ethnic populations to identify race-specific predis-
position genes. However, the results of genetic association
studies may also differ within races and may produce false-
negative or false-positive results as a result of selection bias
of the samples. Thus further studies in the Chinese Han
population, including a larger sample size, are also required
to confirm the effects of the SNP rs1004819 and SNP
rs10889677 on the development of AS.
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